share

(Ala11,22,28)-Vip (Human, Bovine, Porcine, Rat) CAS NO 291524-04-4


Unit Price:

CAS No.:291524-04-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(Ala11,22,28)-Vip (Human, Bovine, Porcine, Rat) is a synthetic, site-specifically modified analog of the Vasoactive Intestinal Peptide (VIP), a critical neuropeptide and hormone. This engineered peptide is designed for advanced research into VIP receptor (VPAC1/VPAC2) signaling, offering enhanced stability and specificity compared to the native sequence. It is an essential tool for pharmaceutical R&D, academic research, and diagnostic development in fields such as neurobiology, immunology, and oncology. The compound is supplied as a high-purity lyophilized powder to ensure reliable and reproducible experimental results.

Application

  • Biomedical Research: Fundamental studies on VIP receptor pharmacology, signal transduction pathways, and physiological functions.
  • Drug Discovery & Development: Used as a reference standard and lead compound in the development of novel therapeutics for inflammatory, neurological, and metabolic disorders.
  • In Vitro Assays: Critical reagent in cell-based assays (e.g., cAMP accumulation, calcium flux) for screening and characterizing VPAC1/VPAC2 receptor agonists and antagonists.
  • Immunology Studies: Investigation of VIP's role in modulating immune responses, T-cell differentiation, and cytokine production.
  • Neuroscience Research: Exploration of neuroprotective effects, neural circuit modulation, and potential in neurodegenerative disease models.
  • Diagnostic Development: Potential use in the development of immunoassays and imaging probes targeting VIP receptors, which are overexpressed in certain tumors.

Basic Information

Item Details
Product Name (Ala11,22,28)-Vip (Human, Bovine, Porcine, Rat)
CAS No. 291524-04-4
Molecular Formula C147H237N43O43S
Molecular Weight 3326.8 g/mol
Synonyms Vasoactive Intestinal Peptide (11-22-28-Ala) analog; [Ala11,22,28]-VIP; VIP analog, alanine-substituted; VIP (human, bovine, porcine, rat) (Ala11,22,28)-; VPAC receptor ligand analog; Research peptide 291524-04-4
EINECS Contact for details

Quality Control

Every batch of (Ala11,22,28)-Vip is manufactured under strict quality systems and undergoes comprehensive analytical characterization. We guarantee high purity (>95%) as determined by reverse-phase HPLC. Identity is confirmed by mass spectrometry (MS) and amino acid analysis. Our quality commitment ensures the material is suitable for sensitive in vitro and in vivo research applications. A detailed Certificate of Analysis (COA) providing batch-specific data for purity, content, and solvent residues is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store the lyophilized powder at -20°C or below. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a dry environment before opening to prevent moisture absorption. Reconstituted solutions should be aliquoted and stored at -80°C to minimize freeze-thaw cycles.

Specification

Item Specification
Appearance White to off-white lyophilized powder
Identification (MS) Consistent with theoretical molecular weight
Purity (HPLC) ≥ 95%
Peptide Content ≥ 80% (by amino acid analysis)
Water Content (KF) ≤ 5.0%
Acetate Content (HPIC) ≤ 10.0%
Solubility Soluble in water or dilute acetic acid

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.